Affiliations 

  • 1 Department of Cardiology, Medanta, The Medicity Hospital, Gurgaon, Haryana, India
  • 2 The Cardiac Arrhythmia Center, Fuwai Cardiovascular Hospital, Beijing, China
  • 3 Department of Cardiology, National Heart Centre of Singapore, Singapore
  • 4 Department of Cardiology, West China Hospital, Chengdu, China
  • 5 Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan
  • 6 Instituto de Cardiología, Fundación Cardio infantil, Centro Internacional de Arritmias, Bogota, Colombia and Universidad de la Sabana, Chía, Colombia
  • 7 Department of Cardiology, Institut Jantung Negara, Kuala Lumpur, Malaysia
  • 8 Cardiology Division, Korea University Medical Center, Seoul, South Korea
  • 9 Department of Roentgen-Endovascular Surgery, Republican Scientific Practical Centre Cardiology, Minsk, Belarus
  • 10 Department of Cardiac Rhythm Management, Medtronic, Mounds View, Minnesota
Pacing Clin Electrophysiol, 2018 12;41(12):1619-1626.
PMID: 30320410 DOI: 10.1111/pace.13526

Abstract

BACKGROUND: Despite available evidence that implantable cardioverter defibrillators (ICDs) reduce all-cause mortality among patients at risk for sudden cardiac death, utilization of ICDs is low especially in developing countries.

OBJECTIVE: To summarize reasons for ICD or cardiac resynchronization therapy defibrillator implant refusal by patients at risk for sudden cardiac arrest (Improve SCA) in developing countries.

METHODS: Primary prevention (PP) and secondary prevention (SP) patients from countries where ICD use is low were enrolled. PP patients with additional risk factors (syncope, ejection fraction 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.